Showing results (91-100 of 443) with videos related to
Sort By:
Pageof 45
Clinical Pharmacology and Therapeutics|December 1, 1995
Sympathomimetic effects of paraxanthine and caffeine in humansN L Benowitz, P Jacob, H Mayan, et al.The Cochrane Database of Systematic Reviews|May 5, 2000
Clonidine for smoking cessationS G Gourlay, L F Stead, N L BenowitzBritish Journal of Pharmacology|April 28, 2001
Endogenous opioids suppress activation of nociceptors by sub-nanomolar nicotineF J Miao, N L Benowitz, J D LevineNeurology|February 1, 1984
Changes in plasma catecholamines after tonic-clonic seizuresR P Simon, M J Aminoff, N L BenowitzThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1981
The cardiovascular and autonomic effects of repeated administration of delta-9-tetrahydrocannabinol to rhesus monkeysA B Fredericks, N L Benowitz, C Y SavanapridiJournal of Clinical Pharmacology|August 1, 1981
Clinical relevance of cannabis tolerance and dependenceR T Jones, N L Benowitz, R I HerningClinical Pharmacology and Therapeutics|May 1, 1985
Propranolol antagonism of phenylpropanolamine-induced hypertensionP R Pentel, R W Asinger, N L BenowitzPharmacology, Biochemistry, and Behavior|December 1, 1986
Mouth versus deep airways absorption of nicotine in cigarette smokersG B Gori, N L Benowitz, C J LynchAnnals of Neurology|February 1, 1986
Status epilepticus: divergence of sympathetic activity and cardiovascular responseN L Benowitz, R P Simon, J R CopelandThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1988
Pharmacodynamic model of tolerance: application to nicotineH C Porchet, N L Benowitz, L B SheinerPageof 45